Literature DB >> 31786235

Quantification of Esophageal Tumor Motion and Investigation of Different Image-Guided Correction Strategies.

Francine E M Voncken1, Sareh Nakhaee2, Barbara Stam2, Lisa Wiersema2, Sophie E Vollenbrock3, Jolanda M van Dieren4, Monique E van Leerdam4, Jan-Jakob Sonke2, Berthe M P Aleman2, Peter Remeijer2.   

Abstract

PURPOSE: To accurately quantify esophageal tumor position variability and to optimize image guided correction strategies.
MATERIAL AND METHODS: Esophageal cancer patients receiving chemoradiotherapy (41.4-50.4 Gy in 23-28 fractions combined with carboplatin plus paclitaxel) were included in a prospective cohort study (NCT02139488). Gold fiducial markers were inserted into the esophageal tumors during diagnostic endoscopic ultrasound. Four-dimensional (4D) planning computed tomography (CT) and daily 4D cone beam (CB) CT scans were acquired. Each CBCT was registered to the planning CT using different regions of interest (bone; 3D), and carina, diaphragm, clinical target volume (CTV), and fiducial markers (4D) for alignment and using the fiducial markers as the true tumor position. Subsequently, a planning target volume (PTV) margin accounting for residual uncertainties, including the average respiratory motion, was calculated for each of these registrations.
RESULTS: Fifty-six patients with tumors located in the proximal (n = 1), mid (n = 7), or distal esophagus (n = 25) or at the gastroesophageal junction (n = 23) were included. The average peak-to-peak respiratory tumor motion was 0.20, 0.92, and 0.34 cm on the planning CT in left-right (LR), cranial-caudal (CC), and anterior-posterior (AP) directions, respectively. The required PTV margin with average motion amplitude, depending on the correction strategy used for image guidance, ranged from 0.8 cm to 1.0 cm, 1.1 cm to 1.6 cm, and 0.7 cm to 0.9 cm in LR, CC, and AP direction, respectively. A registration based on the CTV resulted in the smallest PTV margins (0.8, 1.1, and 0.7 cm in LR, CC, and AP direction, respectively). For bone registration the calculated PTV margins were 1.0, 1.3, and 0.7 cm in LR, CC, and AP directions, respectively. The registration based on the diaphragm increased PTV margins.
CONCLUSIONS: Substantial and anisotropic position variability of esophageal tumors was observed during radiation therapy, and nonuniform margins should be considered. Cranial-caudal PTV margins need to be larger than those commonly used. Target positioning during image-guided radiotherapy could be improved with a CTV registration-based correction strategy.
Copyright © 2019 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31786235     DOI: 10.1016/j.prro.2019.11.012

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  6 in total

1.  In-Air Electron Streaming Effect for Esophageal Cancer Radiotherapy With a 1.5 T Perpendicular Magnetic Field: A Treatment Planning Study.

Authors:  Hongdong Liu; Shouliang Ding; Bin Wang; Yongbao Li; Ying Sun; Xiaoyan Huang
Journal:  Front Oncol       Date:  2020-12-01       Impact factor: 6.244

2.  Review of MR-Guided Radiotherapy for Esophageal Cancer.

Authors:  Sangjune Laurence Lee; Michael Bassetti; Gert J Meijer; Stella Mook
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

3.  Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.

Authors:  M R Boekhoff; R Bouwmans; P A H Doornaert; M P W Intven; J J W Lagendijk; A L H M W van Lier; M J A Rasing; S van de Ven; G J Meijer; S Mook
Journal:  Clin Transl Radiat Oncol       Date:  2022-03-17

4.  Late-course accelerated Hyperfractionation vs. Conventional Fraction Radiotherapy under precise technology plus Concurrent Chemotherapy for Esophageal Squamous Cell Carcinoma: comparison of efficacy and side effects.

Authors:  Hongtao Luo; Shihong Wei; Xiaohu Wang; Ruifeng Liu; Qiuning Zhang; Zhen Yang; Zheng Li; Xiyi Wei; Yuexiao Qi; Lijun Xu
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

5.  Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapy.

Authors:  Jinming Shi; Yuan Tang; Ning Li; Yongwen Song; Shulian Wang; Yueping Liu; Hui Fang; Ningning Lu; Yu Tang; Shunan Qi; Bo Chen; Yexiong Li; Wenyang Liu; Jing Jin
Journal:  Radiat Oncol       Date:  2022-02-03       Impact factor: 3.481

6.  Long-term clinical outcomes of lipiodol marking using standard gastroscopy for image-guided radiotherapy of upper gastrointestinal cancers.

Authors:  Kim Hay Be; Richard Khor; Daryl Lim Joon; Ben Starvaggi; Michael Chao; Sweet Ping Ng; Michael Ng; Leonardo Zorron Cheng Tao Pu; Marios Efthymiou; Rhys Vaughan; Sujievvan Chandran
Journal:  World J Gastroenterol       Date:  2021-11-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.